Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 causes more taste, smell, hair, memory, and concentration issues than other respiratory infections.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

Removing breast implants resolved the patient's symptoms.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Vaccination is the most effective way to reduce COVID-19 transmission.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Long COVID can cause anemia and iron issues, leading to fatigue and slow recovery, especially in men and severe cases.

New-onset fibromyalgia after COVID-19 is poorly understood, needing better definitions and studies.

Medicinal plants might help with post-COVID-19 issues, but more research is needed.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Higher androgen levels might make COVID-19 worse, especially in men.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Systemic retinoids do not increase COVID-19 risk or severity.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Nearly half of the patients had Long COVID, leading to health and work issues, especially in high-risk groups.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Collider bias can distort our understanding of COVID-19 risk and severity.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Hispanic individuals in Northern Nevada were more affected by COVID-19 but had lower mortality rates than non-Hispanics.